A marine-derived antioxidant astaxanthin as a potential neuroprotective and neurotherapeutic agent: A review of its efficacy on neurodegenerative conditions
Article in European Journal of Pharmacology (June 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
GPR30 alleviated subarachnoid hemorrhage-induced blood-brain barrier dysfunction by activating the PI3K/Akt and Nrf2/HO-1 pathways
Article in American Journal of Physiology - Cell Physiology (May 2024)
Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery
Article in Frontiers in Pharmacology (January 2024)